Articles with public access mandates - Huseyin NaciLearn more
Not available anywhere: 5
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and …
H Naci, JJ Brugts, R Fleurence, B Tsoi, H Toor, AE Ades
european Journal of preventive Cardiology 20 (4), 641-657, 2013
Mandates: UK Medical Research Council
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials
H Naci, JJ Brugts, R Fleurence, AE Ades
European journal of preventive cardiology 20 (4), 658-670, 2013
Mandates: UK Medical Research Council
Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis
KN Vokinger, TJ Hwang, DL Carl, Y Laube, WD Ludwig, H Naci, ...
The Lancet Oncology 23 (4), 514-520, 2022
Mandates: Swiss National Science Foundation, National Institute for Health Research …
Faster UK drug approvals by relying on other countries
A Cherla, C Davis, E Mossialos, H Naci
bmj 381, 2023
Mandates: US National Institutes of Health, UK Research & Innovation
Evidence Required for Drugs Granted Accelerated Approval—Reply
H Naci, AS Kesselheim
Jama 318 (24), 2493-2494, 2017
Mandates: Arnold Ventures LLC
Available somewhere: 43
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals …
C Davis, H Naci, E Gurpinar, E Poplavska, A Pinto, A Aggarwal
bmj 359, 2017
Mandates: National Institute for Health Research, UK
How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on …
H Naci, M Salcher-Konrad, S Dias, MR Blum, SA Sahoo, D Nunan, ...
British journal of sports medicine 53 (14), 859-869, 2019
Mandates: Swiss National Science Foundation, UK Medical Research Council
Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US Food and Drug Administration
H Naci, KR Smalley, AS Kesselheim
Jama 318 (7), 626-636, 2017
Mandates: Arnold Ventures LLC
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional …
H Naci, C Davis, J Savović, JPT Higgins, JAC Sterne, B Gyawali, ...
bmj 366, 2019
Mandates: Natural Sciences and Engineering Research Council of Canada, UK Medical …
Prognostic significance of left ventricular noncompaction: systematic review and meta-analysis of observational studies
N Aung, S Doimo, F Ricci, MM Sanghvi, C Pedrosa, SP Woodbridge, ...
Circulation: Cardiovascular Imaging 13 (1), e009712, 2020
Mandates: National Institute for Health Research, UK, Wellcome Trust
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
N Jackson, D Atar, M Borentain, G Breithardt, M van Eickels, M Endres, ...
European heart journal 37 (9), 747-754, 2016
Mandates: German Research Foundation, Volkswagen Foundation, British Heart Foundation …
Cost implications of using different ECG criteria for screening young athletes in the United Kingdom
H Dhutia, A Malhotra, V Gabus, A Merghani, G Finocchiaro, L Millar, ...
Journal of the American College of Cardiology 68 (7), 702-711, 2016
Mandates: British Heart Foundation, National Institute for Health Research, UK
Generating comparative evidence on new drugs and devices before approval
H Naci, M Salcher-Konrad, AS Kesselheim, B Wieseler, L Rochaix, ...
The Lancet 395 (10228), 986-997, 2020
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Decision making under uncertainty: comparing regulatory and health technology assessment reviews of medicines in the United States and Europe
RA Vreman, H Naci, WG Goettsch, AK Mantel‐Teeuwisse, ...
Clinical Pharmacology & Therapeutics 108 (2), 350-357, 2020
Mandates: Arnold Ventures LLC
COVID-19 related mortality and spread of disease in long-term care: a living systematic review of emerging evidence
M Salcher-Konrad, A Jhass, H Naci, M Tan, Y El-Tawil, A Comas-Herrera
MedRxiv, 2020.06. 09.20125237, 2020
Mandates: UK Research & Innovation
Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
H Naci, S Dias, AE Ades
Bmj 349, 2014
Mandates: UK Medical Research Council
Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials
H Naci, JJ Brugts, R Fleurence, AE Ades
QJM: An International Journal of Medicine 106 (4), 299-306, 2013
Mandates: UK Medical Research Council
Generating comparative evidence on new drugs and devices after approval
A Cipriani, JPA Ioannidis, PM Rothwell, P Glasziou, T Li, AF Hernandez, ...
The Lancet 395 (10228), 998-1010, 2020
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention
T Tervonen, H Naci, G van Valkenhoef, AE Ades, A Angelis, HL Hillege, ...
Medical Decision Making 35 (7), 859-871, 2015
Mandates: UK Medical Research Council
Impact of the international recommendations for electrocardiographic interpretation on cardiovascular screening in young athletes
H Dhutia, A Malhotra, G Finocchiaro, A Merghani, M Papadakis, H Naci, ...
Journal of the American College of Cardiology 70 (6), 805-807, 2017
Mandates: British Heart Foundation
Publication and funding information is determined automatically by a computer program